Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Aphasia, Magnetic resonance imaging
Clinical narrative: About 2-3 weeks later, started having difficulty completing sentence/use/reach word to communicate/complete thought.; This is a spontaneous report received from a Consumer or other non HCP.  A 79-year-old male patient received BNT162b2 (BNT162B2), on 04Oct2021 as dose 1, single (Lot number: FE3592) at the age of 78 years intramuscular, in left deltoid for covid-19 immunisation. The patient's relevant medical history included: "sometimes have a little hearing disparity among different "deafness"" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: fluzone high-Dose 2012-13 syr (Left upper arm, intramuscular, U4490AA), administration date: 16Sep2012, when the patient was 69-year-old; fluzone high-Dose 2013-14 syr (Left deltoid, intramuscular, U4713AA), administration date: 26Sep2013, when the patient was 70-year-old; fluzone high-Dose 2014-15 syr (Left deltoid, intramuscular, U4995AA), administration date: 25Aug2014, when the patient was 71-year-old; pneumovax 23 syringe (Left deltoid, K009105), administration date: 15Sep2014, when the patient was 71-year-old; zostavax vial (subcutaneous), administration date: 06Oct2009, when the patient was 66-year-old; fluzone 2009-10 syringe (intramuscular), administration date: 06Oct2009, when the patient was 66-year-old; fluzone high-Dose 2010-11 syr (intramuscular), administration date: 01Oct2010, when the patient was 67-year-old; fluzone high-Dose 2011-2012 syringe (intramuscular), administration date: 02Oct2011, when the patient was 68-year-old; fluzone high-Dose (intramuscular, Left deltoid, UI438AA), administration date: 26Sep2015, when the patient was 72-year-old; prevnar 13 syringe (intramuscular, Left deltoid, M51194), administration date: 18Mar2018, when the patient was 75-year-old; fluzone high-Dose (intramuscular, Left deltoid, UI620AB), administration date: 11Aug2016, when the patient was 73-year-old; fluzone high-Dose (intramuscular, Left deltoid, UI848AB), administration date: 18Sep2017, when the patient was 74-year-old; shingrix vial kit (intramuscular, Left deltoid, 539A2), administration date: 28Mar2018, when the patient was 75-year-old; fluad 2018-2019 syringe (intramuscular, Left deltoid, 250788), administration date: 11Sep2018, when the patient was 75-year-old; shingrix vial kit (intramuscular, Left deltoid, GG2GA), administration date: 22Oct2018, when the patient was 75-year-old; boostrix tdap vaccine syringe (intramuscular, Left deltoid, 54B74), administration date: 31Oct2018, when the patient was 76-year-old; fluad 2019-2020 syringe (intramuscular, Left deltoid, 260382), administration date: 07Aug2019, when the patient was 76-year-old; fluad (intramuscular, Left deltoid, 279794), administration date: 30Aug2020, when the patient was 77-year-old. The following information was reported: APHASIA (non-serious) with onset 2022, outcome "recovering", described as "About 2-3 weeks later, started having difficulty completing sentence/use/reach word to communicate/complete thought.". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: Wife passed away 10Jun2022. About 2-3 weeks later, started having difficulty completing sentence/use/reach word to communicate/complete thought. Have recovered. About 80% of time to be able to communicate/complete thought.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300177736 same patinet, diferrent doses/events;US-PFIZER INC-202300452364 same patinet, diferrent doses/events;